Chemical formula: C₂₁H₃₀N₄O₄  Molecular mass: 402.487 g/mol  PubChem compound: 68867

Active ingredient description

Cinitapride is an agonist of 5-HT4 and 5-HT1 receptors and antagonist of 5-HT2 receptors. Cinitapride is marketed worldwide for the treatment of gastrointestinal disorders related to motility such as indigestion or functional or non-ulcer dyspepsia, gastroesophageal reflux diseases, delay in gastric emptying and vomiting.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A03FA08 A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03F Propulsives → A03FA Propulsives
Discover more medicines within A03FA08

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 66564-14-5
DrugBank Drug: DB08810
KEGG Drug: D07700
PubChem Compound: 68867
RxNorm Ingredient: 21125
SNOMED-CT Concept: 717099009
Cinitapride (substance)
UNII Identifier: R8I97I2L24


Cinitapride is an active ingredient of these brands:

Croatia (HR)

Ecuador (EC)

Mexico (MX)


Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.